These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 10826007)

  • 1. Emerging concepts in antihypertensive therapy: the benefits of angiotensin II blockade.
    Meggs LG; Kodali P
    J Assoc Acad Minor Phys; 1999; 10(2):34-43. PubMed ID: 10826007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of the renin-angiotensin system and target organ protection.
    Iwanami J; Mogi M; Iwai M; Horiuchi M
    Hypertens Res; 2009 Apr; 32(4):229-37. PubMed ID: 19262496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal mechanisms of angiotensin II-induced hypertension.
    Granger JP; Schnackenberg CG
    Semin Nephrol; 2000 Sep; 20(5):417-25. PubMed ID: 11022893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. From mitochondria to disease: role of the renin-angiotensin system.
    de Cavanagh EM; Inserra F; Ferder M; Ferder L
    Am J Nephrol; 2007; 27(6):545-53. PubMed ID: 17785964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pathophysiological and clinical implications of AT(1)/AT(2) angiotensin II receptors in heart failure and coronary and renal failure].
    Sandmann S; Unger T
    Drugs; 2002; 62 Spec No 1():43-52. PubMed ID: 12036388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological properties of angiotensin II antagonists: examining all the therapeutic implications.
    Unger T
    J Renin Angiotensin Aldosterone Syst; 2001 Sep; 2 Suppl 2():S4-7. PubMed ID: 11881101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The role of the selective blocking of angiotensin II receptors in the treatment of cardiovascular diseases].
    Carnovali M
    Clin Ter; 2001; 152(2):103-6. PubMed ID: 11441521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting mechanisms of hypertensive vascular disease with dual calcium channel and renin-angiotensin system blockade.
    Weir MR
    J Hum Hypertens; 2007 Oct; 21(10):770-9. PubMed ID: 17597800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kidney angiotensin receptors and their role in renal pathophysiology.
    Sandberg K; Ji H
    Semin Nephrol; 2000 Sep; 20(5):402-16. PubMed ID: 11022892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of the renin--angiotensin system on the vessel wall: using ACE inhibition to improve endothelial function.
    Neutel JM
    J Hum Hypertens; 2004 Sep; 18(9):599-606. PubMed ID: 15190263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pathophysiological and clinical implications of AT(1) and AT(2) angiotensin II receptors in metabolic disorders: hypercholesterolaemia and diabetes].
    Strawn WB
    Drugs; 2002; 62 Spec No 1():31-41. PubMed ID: 12036387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation and function of extrarenal angiotensin receptors.
    Wang DH; Elijovich F
    Cell Biochem Biophys; 1999; 31(1):1-17. PubMed ID: 10505665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How to explain the differences between renin angiotensin system modulators.
    Levy BI
    Am J Hypertens; 2005 Sep; 18(9 Pt 2):134S-141S. PubMed ID: 16125050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined renin-angiotensin system blockade and dietary sodium restriction impairs cardiomyocyte contractility.
    Trongtorsak P; Morgan TO; Delbridge LM
    J Renin Angiotensin Aldosterone Syst; 2003 Dec; 4(4):213-9. PubMed ID: 14689368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of the renin-angiotensin-aldosterone system in vascular remodeling and inflammation: a clinical review.
    Duprez DA
    J Hypertens; 2006 Jun; 24(6):983-91. PubMed ID: 16685192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical evidence for the cardiovascular benefits of angiotensin receptor blockers.
    Nickenig G; Ostergren J; Struijker-Boudier H
    J Renin Angiotensin Aldosterone Syst; 2006 Jun; 7 Suppl 1():S1-7. PubMed ID: 16969748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Blockade of the renin-angiotensin system by a combination of ACE inhibitors and AT1 receptor antagonists].
    Azizi M
    Rev Prat; 2004 Jun; 54(11):1167-74. PubMed ID: 15496022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of angiotensin II in hypertension and end-organ damage.
    Pool JL
    Int J Clin Pract Suppl; 2000 Aug; (111):4-8. PubMed ID: 15977400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pathophysiological and clinical implications of AT(1) and AT(2) angiotensin II receptors in essential hypertension].
    Burnier M
    Drugs; 2002; 62 Spec No 1():21-9. PubMed ID: 12036386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.